Hamari Chemicals, Ltd. was invited to present at
the Dietitians Australia 2021 Conference
in July 11-13, 2021.
Functional dyspepsia and Gastro-esophageal reflux disease are two highly prevalent upper GIT disorders, which significantly impair quality of life. Chelated compounds of zinc have demonstrated efficacy for addressing the symptoms and underlying drivers of upper digestive complaints and represent a compelling support to conventional drug therapy. Attendees will understand the evidence for, indications and contraindications for these key clinically trialed nutritional compounds.
Hamari will have a 20 minutes presentation focusing on PepZinGI’s safety and efficacy.